KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $433,348,000 | +73.4% | 2,410,034 | 0.0% | 77.71% | +17.0% |
| Q2 2017 | $249,848,000 | +35.0% | 2,410,034 | +2.2% | 66.42% | +13.3% |
| Q1 2017 | $185,086,000 | +75.0% | 2,358,084 | 0.0% | 58.62% | +20.5% |
| Q4 2016 | $105,736,000 | -19.7% | 2,358,084 | 0.0% | 48.63% | +22.5% |
| Q3 2016 | $131,723,000 | +11.7% | 2,358,084 | 0.0% | 39.70% | -10.7% |
| Q2 2016 | $117,904,000 | +8.9% | 2,358,084 | 0.0% | 44.44% | +18.0% |
| Q1 2016 | $108,260,000 | -25.5% | 2,358,084 | 0.0% | 37.66% | -8.2% |
| Q4 2015 | $145,305,000 | +10.7% | 2,358,084 | 0.0% | 41.00% | -16.4% |
| Q3 2015 | $131,298,000 | -8.7% | 2,358,084 | 0.0% | 49.02% | -0.5% |
| Q2 2015 | $143,772,000 | +5.7% | 2,358,084 | 0.0% | 49.28% | -6.5% |
| Q1 2015 | $136,014,000 | +0.0% | 2,358,084 | 0.0% | 52.71% | -5.8% |
| Q4 2014 | $135,991,000 | – | 2,358,084 | – | 55.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |